Appendix: Description of the DIETRON model



Similar documents
Margarines and Heart Disease. Do they protect?

Nutrition et prévention : Données issues des cohortes et des études d intervention

Analysing research on cancer prevention and survival. Diet, nutrition, physical activity and breast cancer survivors. In partnership with

Draft comprehensive global monitoring framework and targets for the prevention and control of noncommunicable diseases

CORPORATE HEALTH LOWERING YOUR CHOLESTEROL & BLOOD PRESSURE

General and Abdominal Adiposity and Risk of Death in Europe

Dietary Guidance Statements An Industry Perspective

Steven Allender, Peter Scarborough, Viv Peto and Mike Rayner

FACT SHEET N 394 UPDATED MAY Healthy diet

Mediterranean diet: A heart-healthy eating plan Source: mayoclinic.org/mediterranean-diet

Food Poverty and Health

Proposed FDA Rule To Ban Partially Hydrogenated (PHO) Oils. Johari Minal

25-hydroxyvitamin D: from bone and mineral to general health marker

Vitamin A Deficiency: Counting the Cost in Women s Lives

Disclosure of Relationships

Healthy life resources for the cancer community. Tonight: Healthy Eating with Diane B. Wilson, EdD, RD. January 18, 2012

High Blood Pressure in People with Diabetes:

3.5% 3.0% 3.0% 2.4% Prevalence 2.0% 1.5% 1.0% 0.5% 0.0%

Karen Kovach M.S, R.D Chief Scientific Officer Weight Watchers International Inc.

Absolute cardiovascular disease risk assessment

Appendix. Appendix Figure 1: Trends in age-standardized cardiometabolic (CVD and diabetes) mortality by country.

Mild Cognitive Impairment

Listen to your heart: Good Cardiovascular Health for Life

Your Results. For more information visit: Name: Date: In partnership with

Foods with a high fat quality are essential for healthy diets. Dr. H. Zevenbergen Unilever Research&Development

Nutrition and Parkinson s Disease: Can food have an impact? Sarah Zangerle, RD, CD Registered Dietitian Froedtert Memorial Lutheran Hospital

Rapid review of the evidence Effectiveness of food reformulation as a strategy to improve population health

Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis

The benefits of prevention: healthy eating and active living

Η δίαιτα στην πρόληψη του αγγειακού εγκεφαλικού επεισοδίου

Section C. Diet, Food Production, and Public Health

Absolute cardiovascular disease risk management

ADULT HYPERTENSION PROTOCOL STANFORD COORDINATED CARE

High Blood Pressure (Hypertension)

Australian heart disease statistics 2014

The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery

2012 Executive Summary

Chapter 1. Burden: mortality, morbidity and risk factors

Risk estimation and the prevention of cardiovascular disease. A national clinical guideline

Sophie Petersen, Viv Peto and Mike Rayner. British Heart Foundation Health Promotion Research Group Department of Public Health, University of Oxford

A COMPARATIVE STUDY OF THE FATTY ACID COMPOSITION OF FORTY MARGARINES AVAILABLE IN SOUTH AFRICA

Primary Care Guidance Program: Non-Alcohol related Fatty Liver Disease (NAFLD) Guidance on Management in Primary Care

Coronary Heart Disease (CHD) Brief

Even though diet can influence your risk of developing cancer, there is little evidence that special foods can be used to cure existing cancers.

ESPEN Congress Brussels 2005

Underwriting Critical Illness Insurance: A model for coronary heart disease and stroke

How To Treat Dyslipidemia

Fewer people with coronary heart disease are being diagnosed as compared to the expected figures.

Cardiovascular Disease Risk Factors

Mortality in vegetarians and nonvegetarians: detailed findings from a collaborative analysis of 5 prospective studies 1 3

Nutrition Requirements

MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES

ECONOMIC COSTS OF PHYSICAL INACTIVITY

Primary Care Management of Women with Hyperlipidemia. Julie Marfell, DNP, BC, FNP, Chairperson, Department of Family Nursing

Diabetes and Hypertension Care For Adults in Primary Care Settings

Take Care New York. #TakeCareNY if you are tweeting about this event. May 2013

Adult Weight Management Training Summary

The Influence of Infant Health on Adult Chronic Disease

Risk factors and public health in Denmark Summary report

National Food Safety Standard Standard for nutrition labelling of prepackaged foods

Cohort Studies. Sukon Kanchanaraksa, PhD Johns Hopkins University

Epidemiology of Hypertension 陈 奕 希 李 禾 园 王 卓

Triglycerides: Frequently Asked Questions

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

JNC-8 Blood Pressure and ACC/AHA Cholesterol Guideline Updates. January 30, 2014

Dark chocolate as a functional food

Maintaining Healthy Body Mass Index (BMI) Through Physical Activity and Diet Pitfalls of Fad Dieting. Julia Sosa, MS,RD,LD ADPH

Statins and Risk for Diabetes Mellitus. Background

Technology Assessment

Cardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011

Jill Malcolm, Karen Moir

White Paper: Biomarker-Based Validation of Diet and Physical Activity Assessment Tools in Existing Cohorts

The Canadian Association of Cardiac

Social inequalities in all cause and cause specific mortality in a country of the African region

DIET AND EXERCISE STRATEGIES FOR WEIGHT LOSS AND WEIGHT MAINTENANCE

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

High Blood Pressure (Essential Hypertension)

Blood Pressure Assessment Program Screening Guidelines

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

The American Cancer Society Cancer Prevention Study I: 12-Year Followup

Weight Loss Surgery DA participants- 18 months later. By: Caitlyn Patrick and Evan Morgan

Chapter 5 DASH Your Way to Weight Loss

Transcription:

Appendix: Description of the DIETRON model Much of the description of the DIETRON model that appears in this appendix is taken from an earlier publication outlining the development of the model (Scarborough et al., 2010). The DIETRON model is based on a conceptual framework that leads from consumption of foods and nutrients through to biological risk factors for ill health, through to adverse health outcomes. Food components (e.g. fruit, vegetables, saturated fat etc.) were included in the model as inputs if either (1) a quantitative estimate of the association between the food component and CHD, stroke or has been derived from a meta-analysis of cohort or case-control studies, or (2) a quantitative estimate of the association between the food component and a biological risk factor has been derived from a meta-analysis of randomised trials, cohort or case-control studies, and a further quantitative assessment of the association between the biological risk factor and CHD, stroke or has been derived from a meta-analysis of cohort or case-control studies. An additional condition was assigned for links with : that the association be defined as probable or convincing by the World Cancer Research Fund (AICR /. The parameterisation of the relationship between physical activity levels, total energy intake and body mass index was not provided by a meta-analysis, but from an equation reported in the literature derived from the principles of conservation of energy (Christiansen and Garby,. Meta-analyses were identified through computerised database and hand searching, and priority was given to meta-analyses of trials, followed by cohort studies and then case-control studies. Where age- and sex-specific quantitative estimates where available they were included in the model. The DIETRON model relies on four key assumptions, which are detailed in table A1. Details on the meta-analyses parameterising the links in the DIETRON model are provided in table A2. The parameters used in the DIETRON model are provided in table A3. In some instances, meta-analyses were available that would allow us to either model the association between food component and health outcome directly or via a biological risk factor. In all such instances, we chose to model via the biological risk factor in order to follow the general principle that, where data are available, it is advantageous to generate structural models of disease risk that incorporate the underlying system under investigation (Murray et al., 2003). The connections included in the DIETRON model are displayed in figures A1-A6, where a dashed line indicates an inverse relationship, a solid line indicates a positive relationship, and a dotted line indicates a U-shaped relationship. All of the relationships in the DIETRON model are assumed to follow a log-linear dose response relationship, with the exception of the relationships between obesity levels and health outcomes. Here, the model calculates a shift in the distribution of BMI within a population under a counterfactual scenario, and models the total amount of risk in the counterfactual scenario on the basis of risk levels at different levels of BMI. In this way, the DIETRON model can accommodate non-linear risk relationships between obesity and health outcomes. Figure A1: Links between fruit and vegetables and health outcomes in the DIETRON model Figure A2: Links between fibre and health outcomes in the DIETRON model Figure A3: Links between fatty acids and health outcomes in the DIETRON model Figure A4: Links between salt and health outcomes in the DIETRON model Figure A5: Links between physical activity and total energy intake and health outcomes in the DIETRON model Figure A6: Conceptual framework underlying the DIETRON model Table A1: Assumptions incorporated in the DIETRON model 1 Wherever possible, it is advantageous to generate structural models of disease risk that incorporate the underlying system under investigation. 2 Changes in risk associated with changes in more than one food component are combined multiplicatively (e.g. if changing food component X reduces risk of a health outcome by 10% and changing food component Y reduces risk by 12%, then changing X and Y together reduces risk by 100%*(1-(1-0.10)*(1-0.12)) = 20.8% 3 With the exception of obesity, changes in risk in the DIETRON model follow a loglinear dose-response relationship (e.g. a change in consumption of fruit and vegetables from 2 to 3 portions per day has the same effect as a change in consumption from 7 to 8 portions per day).

1 Wherever possible, it is advantageous to generate structural models of disease risk that incorporate the underlying system under investigation. 4 Changes between baseline and counterfactual food consumption distributions will be made by all individuals within the population equally (i.e. a population shift in the overall distribution of consumption). Table A2 Meta-analyses used to parameterise the DIETRON model Food Outcome Meta-analysis details Adjustments Log-linear dose-response risk factor relationship Fruit Vegetables Fibre Total fat, saturated fat, MUFA, PUFA, dietary Trans fats CHD (I20-25) Six cohort studies (3,446 Stroke (I60-69) Five cohort studies (1,853 Mouth, pharynx, larynx (C00-14) (C15) Lung (C34) Stomach Source observed? Age, smoking, obesity (Dauchet et al., 2006) Age, hypertension, (Dauchet et smoking, obesity al., 2005) Seven case-control studies Smoking No (AICR / Eight case-control studies (AICR / Fourteen cohort studies Smoking (AICR / Eight cohort studies No (AICR / Age, smoking, obesity (Dauchet et al., 2006) (C16) CHD Seven cohort studies (3,833 Stroke Four cohort studies (933 Mouth, pharynx, larynx Stomach Four case-control studies CHD Ten cohort studies (2,011 CHD deaths) Age, hypertension, smoking, obesity, blood, physical activity, energy intake, alcohol intake Sex, smoking, alcohol intake No (Dauchet et al., 2005) (AICR / Five case-control studies (AICR / Seven cohort studies No (AICR / Age, energy intake, (Pereira et al., smoking, obesity, physical 2004) activity, education, alcohol intake, multiple vitamin use, raised, hypertension, dietary saturated fat, PUFA and 227 dietary intervention studies with diets persisting at least two weeks 40 dietary intervention studies with diets persisting at least two weeks Age, weight, other dietary fat measures Age, weight, other dietary fat measures (Clarke et al., 1997) (Clarke et al., 1997)

risk factor Physical activity, total energy intake Blood pressure Obesity Outcome Meta-analysis details Adjustments Log-linear Source dose-response relationship observed? Stomach Two cohort studies. (AICR / Blood pressure Obesity (body mass index) 28 randomised controlled trials in hypertensive and normotensive individuals Equation derived from principles of conservation of energy CHD 61 cohort studies (33,744 Stroke 61 cohort studies (11,663 CHD 61 cohort studies (34,283 Stroke 61 cohort studies (11,960 All potentially confounding factors (He and MacGregor, 2002; He and MacGregor, 2003) n/a (Christiansen and Garby, Age, sex 2007) Age, sex No Blood, diabetes, weight, alcohol intake, smoking Blood, diabetes, weight, alcohol intake, smoking 2007) CHD 57 cohort studies Age, sex, smoking Risk at each stage of distribution modelled (see Table A3) Stroke 57 cohort studies Age, sex, smoking Risk at each stage of distribution modelled (see Table A3) Four case-control studies (AICR / 2009) 2009) 17 cohort studies Smoking (AICR / 28 cohort studies (AICR / 16 cohort studies (AICR / 15 cohort studies (AICR / Seven cohort studies. Smoking (AICR / Four cohort studies. (AICR / Pancreas (C25) Colorectum (C18) Breast (C50) Endometrial (C54.1) Kidney (C64) Gallbladder (C23) - indicates that either the adjusted factors or the dose-response relationship were not reported. ICD-10 codes are provided in brackets for the first entry of each disease. MUFA mono-unsaturated fatty acids; PUFA poly-unsaturated fatty acid. Number of events is provided where reported in the source document. Table A3: Parameters used in the DIETRON model

biological risk factor Outcome Unit of change Relative risk (95% confidence intervals) Fruit CHD Stroke 106g/day 106g/day 0.93 (0.89, 0.96) 0.89 (0.85, 0.93) M/L/P 100g/day 0.72 (0.59, 0.87) 100g/day 0.56 (0.42, 0.74) Lung 80g/day 0.94 (0.90, 0.97) Stomach 100g/day 0.95 (0.89, 1.02) Vegetables CHD Stroke 106g/day 106g/day 0.89 (0.83, 0.95) 0.97 (0.92, 1.02) M/L/P 50g/day 0.72 (0.63, 0.82) 50g/day 0.87 (0.72, 1.05) Stomach 100g/day 0.98 (0.91, 1.06) Fibre CHD Stomach 10g/day 1g/day 0.81 (0.72, 0.92) 1.08 (1.00, 1.17) Serum CHD 1mmol/l decrease Under 49: 0.44 (0.42, 0.48) 50-59: 0.58 (0.56, 0.61) 60-69: 0.72 (0.69, 0.74) 70-79: 0.82 (0.80, 0.85) Over 79: 0.85 (0.82, 0.89) Stroke 1mmol/l decrease Under 59: 0.90 (0.84, 0.97) 60-69: 1.02 (0.97, 1.08) 70-79: 1.04 (0.99, 1.09) Over 79: 1.06 (1.00, 1.13) Blood pressure CHD 20mmHg SBP decrease Under 49: 0.49 (0.45, 0.53) 50-59: 0.50 (0.49, 0.52) 60-69: 0.54 (0.53, 0.55) 70-79: 0.60 (0.58, 0.61) Over 79: 0.67 (0.64, 0.70) Stroke 20mmHg SBP decrease Under 49: 0.36 (0.32, 0.40) 50-59: 0.38 (0.35, 0.40) 60-69: 0.43 (0.41, 0.45) 70-79: 0.50 (0.48, 0.52) Over 79: 0.67 (0.63, 0.71) Body mass index Food component Total fat Saturated fat CHD 5kg/m 2 Men, BMI 15-25: 1.27 (1.16, 1.39) Women, BMI 15-25: 1.01 (0.86, 1.18) Men, BMI 25-50: 1.42 (1.35, 1.48) Women, BMI 25-50: 1.35 (1.28, 1.43) Stroke 5kg/m 2 BMI 15-25: 0.92 (0.82, 1.03) BMI 25-50: 1.39 (1.31, 1.48) 1kg/m 2 1.11 (1.07, 1.15) Pancreas 5kg/m 2 1.14 (1.07, 1.22) Colorectum 1kg/m 2 1.03 (1.02, 1.04) Breast 2kg/m 2 Under 60: 0.94 (0.92, 0.95) Over 60: 1.03 (1.01, 1.04) Endometrial 5kg/m 2 1.52 (1.35, 1.72) Kidney 5kg/m 2 1.31 (1.24, 1.39) Gallbladder 5kg/m 2 1.23 (1.15, 1.32) Outcome Unit of change Regression parameter (95% confidence intervals 0.020 (0.010, 0.030) 0.052 (0.046, 0.058)

biological risk factor MUFAs PUFAs Dietary Trans fats Total energy intake / physical activity level Outcome Unit of change Relative risk (95% confidence intervals) Systolic blood pressure (mmhg) Change in body weight (kg) 3g/day reduction 0.005 (-0.001, 0.011) 0.026( 0.034, 0.018) 0.001 (0.001, 0.001) 0.038 (0.018, 0.058) 2.50( 2.85, 2.15) 1MJ/PAL Men: 17.7 Women: 20.7 References: American Institute for Cancer Research (AICR) and World Cancer Research Fund (WCRF). Food, nutrition, physical activity and the prevention of : a global perspective. Washington DC: AICR, 2007. Christiansen E, Garby L. Prediction of body weight changes caused by changes in energy balance. Eur J Clin Investigation, 2002;32:826-830. Clarke R, Frost C, Collins R, et al. Dietary lipids and blood : quantitative metaanalysis of metabolic ward studies. BMJ. 1997;314:112. Dauchet L, Amouyel P, Dallongeville J. Fruit and vegetable consumption and risk of stroke: a meta-analysis of cohort studies. Neurology. 2005;65:1193-1197. Dauchet L, Amouyel P, Hercberg S, et al. Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies. J Nutr. 2006;136:2588-2593. He F, MacGregor G. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens. 2002;16:761-770. He F, MacGregor G. How far should salt intake be reduced? Hypertension. 2003;42:1093-1099. Murray C, Ezzati M, Lopez A, et al. Comparative quantification of health risks: conceptual framework and methodological issues. Population Health Metrics. 2003:1;1-20. Pereira M, O Reilly E, Augustsson K, et al. Dietary fiber and risk of coronary heart disease. A pooled analysis of cohort studies. Arch Intern Med. 2004;164:370-376. Prospective Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913. Prospective Collaboration. Blood and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007;370:1829-1839. Prospective Collaboration. Body-mass index and cause-specific mortality in 900,000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083-1096. Scarborough P, Nnoaham K, Clarke D, et al. Modelling the impact of a healthy diet on cardiovascular disease and mortality. J Epidemiol Comm Health, 2010.doi:10.1136/jech.2010.114520